DUBLIN, Ireland--(BUSINESS WIRE)--Further strengthening its broad line of neurovascular products to treat unruptured brain aneurysms, Covidien plc (NYSE:COV) announced the European launch of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results